Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
1987-10-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0023-2173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
625-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3626430-Ascorbic Acid,
pubmed-meshheading:3626430-Cells, Cultured,
pubmed-meshheading:3626430-Chemotaxis, Leukocyte,
pubmed-meshheading:3626430-Humans,
pubmed-meshheading:3626430-Immune Tolerance,
pubmed-meshheading:3626430-Monocytes,
pubmed-meshheading:3626430-Substance-Related Disorders
|
pubmed:year |
1987
|
pubmed:articleTitle |
"In vitro" improvement of defective monocyte chemotaxis in intravenous drug abusers after incubation with ascorbic acid.
|
pubmed:publicationType |
Journal Article
|